408 results
Page 6 of 21
6-K
EX-99.1
9k36daax
1 Dec 14
Live Filing
12:00am
6-K
EX-99.1
shdpgo 0t1h
1 Dec 14
Teva Announces Launch of Generic Exforge HCT® Tablets In the United States
12:00am
6-K
EX-99.1
aozupw ejo
26 Nov 14
Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
12:00am
6-K
EX-99.1
g1b9wkv05cp j2g
18 Nov 14
Live Filing
12:00am
6-K
EX-99.1
43hfnknjauzs9
7 Nov 14
Late Stage Data to be Presented at ACAAI 2014
12:00am
6-K
EX-99.1
qz5ro1l0mu eu
7 Nov 14
Live Filing
12:00am
6-K
EX-99.1
d948o5k ij2
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
m6gc gimsmw3b
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
ufputbshu 8pc92f
8 Oct 14
Live Filing
12:00am
6-K
EX-99.1
hb5ms ptzv24kclnq5p
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
jsotctl
12 Sep 14
Teva Presents Gene Expression Analysis at Joint ACTRIMS-ECTRIMS Meeting Demonstrating COPAXONE® (glatiramer acetate injection) Has a Complex Profile
12:00am
6-K
EX-99.1
doo c0sr0u8dfm7bg7fs
12 Sep 14
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
12:00am
6-K
EX-99.1
zzjmnr5t2bw130sw
11 Sep 14
Live Filing
12:00am
6-K
EX-99.1
xh63ug31p30fjo2 v4dm
8 Sep 14
Successful Completion of Phase Iii Program for Teva’s Reslizumab
12:00am
6-K
EX-99.1
r4jyv7n8hrsf 53u6d
4 Sep 14
Teva Announces Launch of Generic Baraclude® TABLETS,0.5MG and 1MG, In the United States
12:00am
6-K
EX-99.1
8zqmzc4c
3 Sep 14
Live Filing
12:00am
6-K
EX-99.1
nzx54v4uw4x9cz6
3 Sep 14
Teva Launches Syncaretm Home Administration Support Program for Patients on Synribo® (Omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
is5 kp54h01ig
3 Sep 14
Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca
12:00am
6-K
EX-99.1
gjprb 8muqt
2 Sep 14
Live Filing
12:00am
6-K
EX-99.1
hjd3ddry
7 Aug 14
Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
12:00am